Search for Clinical Trial Results

Sponsored By

Alpha 1-Antitrypsin Deficiency - 59 Studies Found

Status Study
Completed Study Name: Zemaira in Subjects With Emphysema Due to Alpha1-Proteinase Inhibitor Deficiency
Condition:
  • Alpha1-proteinase Inhibitor Deficiency
  • Emphysema

Date: 2005-12-02
Interventions:
  • Biological: Alpha1-proteinase inhibitor

Completed Study Name: Extension Study of Zemaira® i.v. Administration in Subjects With Emphysema Due to alpha1-proteinase Inhibitor Deficiency.
Condition:
  • Emphysema
  • Alpha 1-proteinase Inhibitor Deficiency

Date: 2008-04-29
Interventions: Biological: Alpha1- proteinase inhibitor [human] Lyophilized preparation of 60 mg/kg body weight intrave
Completed Study Name: Polygen Defi-Alpha: Genetic Polymorphisms Study in Children With Alpha-1 Antitrypsin Deficiency, Included in the DEFI-ALPHA Cohort
Condition: Children With a Deficiency of Alpha-1 Antitrypsin
Date: 2013-05-22
Interventions: Other: blood sampling A blood sampling will be performed for the genetic analysis and the measurement of
Completed Study Name: GLASSIA Infusion Rate Study
Condition:
  • Alpha1-antitrypsin Deficiency
  • Healthy

Date: 2012-07-23
Interventions:
  • Biological: Alpha1-proteinase inhibitor

Terminated Study Name: Aralast alpha1-proteinase Inhibitor Surveillance Study
Condition: Alpha 1-Antitrypsin (AAT) Deficiency
Date: 2006-04-10
Interventions: Drug: ARALAST Alpha1-Proteinase Inhibitor Weekly ARALAST infusions for 2 years, dose and mode of adminis
Active, not recruiting Study Name: Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
Condition: Type 1 Diabetes Mellitus
Date: 2014-03-11
Interventions:
  • Biological: 180 mg/kg Alpha1-PI

Completed Study Name: Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs
Condition:
  • Alpha-1 Antitrypsin Deficiency
  • AAT Defici
    Date: 2013-04-25
    Interventions:
    • Procedure: History and physical exam.

Completed Study Name: Safety and Tolerability Study of Liquid Alpha1 Proteinase Inhibitor (API) in Subjects With Cystic Fibrosis
Condition: Cystic Fibrosis
Date: 2011-05-03
Interventions:
  • Biological: CR002 Liquid API A
Completed Study Name: Genomic Research in Sarcoidosis
Condition: Sarcoidosis
Date: 2013-04-09
Completed Study Name: Characterization of the Pathobiology of Early Lung Destruction in Alpha 1-Antitrypsin Deficient Individuals
Condition:
  • Emphysema
  • Lung Diseases, Obstructive
  • Date: 1999-11-03
<<< Previous | Next >>>